Literature DB >> 19063969

Tyrosine dephosphorylation regulates AMPAR internalisation in mGluR-LTD.

Clare M Gladding1, Valerie J Collett, Zhengping Jia, Zafar I Bashir, Graham L Collingridge, Elek Molnár.   

Abstract

Long-term depression (LTD) can be induced at hippocampal CA1 synapses by activation of either NMDA receptors (NMDARs) or group I metabotropic glutamate receptors (mGluRs), using their selective agonists NMDA and (RS)-3,5-dihydroxyphenylglycine (DHPG), respectively. Recent studies revealed that DHPG-LTD is dependent on activation of postsynaptic protein tyrosine phosphatases (PTPs), which transiently dephosphorylate tyrosine residues in AMPA receptors (AMPARs). Here we show that while both endogenous GluR2 and GluR3 AMPAR subunits are tyrosine phosphorylated at basal activity, only GluR2 is dephosphorylated in DHPG-LTD. The tyrosine dephosphorylation of GluR2 does not occur in NMDA-LTD. Conversely, while NMDA-LTD is associated with the dephosphorylation of GluR1-serine-845, DHPG-LTD does not alter the phosphorylation of this site. The increased AMPAR endocytosis in DHPG-LTD is PTP-dependent and involves tyrosine dephosphorylation of cell surface AMPARs. Together, these results indicate that the subunit selective tyrosine dephosphorylation of surface GluR2 regulates AMPAR internalisation in DHPG-LTD but not in NMDA-LTD in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19063969     DOI: 10.1016/j.mcn.2008.10.014

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  33 in total

1.  A STEP forward in neural function and degeneration.

Authors:  Matthew L Baum; Pradeep Kurup; Jian Xu; Paul J Lombroso
Journal:  Commun Integr Biol       Date:  2010-09

2.  Homeostatic scaling requires group I mGluR activation mediated by Homer1a.

Authors:  Jia-Hua Hu; Joo Min Park; Sungjin Park; Bo Xiao; Marlin H Dehoff; Sangmok Kim; Takashi Hayashi; Martin K Schwarz; Richard L Huganir; Peter H Seeburg; David J Linden; Paul F Worley
Journal:  Neuron       Date:  2010-12-22       Impact factor: 17.173

Review 3.  Posttranslational regulation of AMPA receptor trafficking and function.

Authors:  Wei Lu; Katherine W Roche
Journal:  Curr Opin Neurobiol       Date:  2011-10-14       Impact factor: 6.627

Review 4.  Taking STEPs forward to understand fragile X syndrome.

Authors:  Susan M Goebel-Goody; Paul J Lombroso
Journal:  Results Probl Cell Differ       Date:  2012

5.  Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.

Authors:  A Ledonne; A Nobili; E C Latagliata; V Cavallucci; E Guatteo; S Puglisi-Allegra; M D'Amelio; N B Mercuri
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

6.  Tyrosine phosphorylation of the AMPA receptor subunit GluA2 gates homeostatic synaptic plasticity.

Authors:  Adeline J H Yong; Han L Tan; Qianwen Zhu; Alexei M Bygrave; Richard C Johnson; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

7.  The δ2 glutamate receptor gates long-term depression by coordinating interactions between two AMPA receptor phosphorylation sites.

Authors:  Kazuhisa Kohda; Wataru Kakegawa; Shinji Matsuda; Tadashi Yamamoto; Hisashi Hirano; Michisuke Yuzaki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

8.  Target- and input-dependent organization of AMPA and NMDA receptors in synaptic connections of the cochlear nucleus.

Authors:  María E Rubio; Yugo Fukazawa; Naomi Kamasawa; Cheryl Clarkson; Elek Molnár; Ryuichi Shigemoto
Journal:  J Comp Neurol       Date:  2014-07-29       Impact factor: 3.215

Review 9.  The AMPA Receptor Code of Synaptic Plasticity.

Authors:  Graham H Diering; Richard L Huganir
Journal:  Neuron       Date:  2018-10-24       Impact factor: 17.173

Review 10.  Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms.

Authors:  Clare M Gladding; Stephen M Fitzjohn; Elek Molnár
Journal:  Pharmacol Rev       Date:  2009-11-19       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.